Literature DB >> 17318262

Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.

Baskaran Govindarajan1, James E Sligh, Bethaney J Vincent, Meiling Li, Jeffrey A Canter, Brian J Nickoloff, Richard J Rodenburg, Jan A Smeitink, Larry Oberley, Yuping Zhang, Joyce Slingerland, Rebecca S Arnold, J David Lambeth, Cynthia Cohen, Lu Hilenski, Kathy Griendling, Marta Martínez-Diez, José M Cuezva, Jack L Arbiser.   

Abstract

Melanoma is the cancer with the highest increase in incidence, and transformation of radial growth to vertical growth (i.e., noninvasive to invasive) melanoma is required for invasive disease and metastasis. We have previously shown that p42/p44 MAP kinase is activated in radial growth melanoma, suggesting that further signaling events are required for vertical growth melanoma. The molecular events that accompany this transformation are not well understood. Akt, a signaling molecule downstream of PI3K, was introduced into the radial growth WM35 melanoma in order to test whether Akt overexpression is sufficient to accomplish this transformation. Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism. Subcutaneous implantation of WM35 cells overexpressing Akt led to rapidly growing tumors in vivo, while vector control cells did not form tumors. We demonstrated that Akt was associated with malignant transformation of melanoma through at least 2 mechanisms. First, Akt may stabilize cells with extensive mitochondrial DNA mutation, which can generate ROS. Second, Akt can induce expression of the ROS-generating enzyme NOX4. Akt thus serves as a molecular switch that increases angiogenesis and the generation of superoxide, fostering more aggressive tumor behavior. Targeting Akt and ROS may be of therapeutic importance in treatment of advanced melanoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318262      PMCID: PMC1797605          DOI: 10.1172/JCI30102

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.

Authors:  M Y Hsu; D T Shih; F E Meier; P Van Belle; J Y Hsu; D E Elder; C A Buck; M Herlyn
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 2.  Mitochondrial biogenesis in the liver during development and oncogenesis.

Authors:  J M Cuezva; L K Ostronoff; J Ricart; M López de Heredia; C M Di Liegro; J M Izquierdo
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

3.  ATF2 confers radiation resistance to human melanoma cells.

Authors:  Z Ronai; Y M Yang; S Y Fuchs; V Adler; M Sardana; M Herlyn
Journal:  Oncogene       Date:  1998-01-29       Impact factor: 9.867

4.  Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

Authors:  J Peli; M Schröter; C Rudaz; M Hahne; C Meyer; E Reichmann; J Tschopp
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase.

Authors:  Baskaran Govindarajan; Robert Klafter; Mark Steven Miller; Claire Mansur; Melissa Mizesko; Xianhe Bai; Kenneth LaMontagne; Jack L Arbiser
Journal:  Mol Med       Date:  2002-01       Impact factor: 6.354

6.  Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.

Authors:  K Irani; Y Xia; J L Zweier; S J Sollott; C J Der; E R Fearon; M Sundaresan; T Finkel; P J Goldschmidt-Clermont
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

7.  An NAD(P)H oxidase regulates growth and transcription in melanoma cells.

Authors:  Sukhdev S Brar; Thomas P Kennedy; Anne B Sturrock; Thomas P Huecksteadt; Mark T Quinn; A Richard Whorton; John R Hoidal
Journal:  Am J Physiol Cell Physiol       Date:  2002-06       Impact factor: 4.249

8.  v-Ha-ras mitogenic signaling through superoxide and derived reactive oxygen species.

Authors:  Ji-Qin Yang; Garry R Buettner; Frederick E Domann; Qiang Li; John F Engelhardt; Christine Darby Weydert; Larry W Oberley
Journal:  Mol Carcinog       Date:  2002-04       Impact factor: 4.784

9.  Ras and Rac as activators of reactive oxygen species (ROS).

Authors:  Herbert Archer; Dafna Bar-Sagi
Journal:  Methods Mol Biol       Date:  2002

10.  Regulation of cell death protease caspase-9 by phosphorylation.

Authors:  M H Cardone; N Roy; H R Stennicke; G S Salvesen; T F Franke; E Stanbridge; S Frisch; J C Reed
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

View more
  117 in total

1.  Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.

Authors:  Yongping Shao; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.

Authors:  David A Kircher; Kirby A Trombetti; Mark R Silvis; Gennie L Parkman; Grant M Fischer; Stephanie N Angel; Christopher M Stehn; Sean C Strain; Allie H Grossmann; Keith L Duffy; Kenneth M Boucher; Martin McMahon; Michael A Davies; Michelle C Mendoza; Matthew W VanBrocklin; Sheri L Holmen
Journal:  Mol Cancer Res       Date:  2019-05-28       Impact factor: 5.852

3.  Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth.

Authors:  Saverio Marchi; Mariangela Corricelli; Alessio Branchini; Veronica Angela Maria Vitto; Sonia Missiroli; Giampaolo Morciano; Mariasole Perrone; Mattia Ferrarese; Carlotta Giorgi; Mirko Pinotti; Lorenzo Galluzzi; Guido Kroemer; Paolo Pinton
Journal:  EMBO J       Date:  2018-11-30       Impact factor: 11.598

4.  Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress.

Authors:  Sathish Kumar Natarajan; Donald F Becker
Journal:  Cell Health Cytoskelet       Date:  2012-02-01

5.  Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4.

Authors:  Natalie Nguyen; Arati Sharma; Nhung Nguyen; Arun K Sharma; Dhimant Desai; Sung Jin Huh; Shantu Amin; Craig Meyers; Gavin P Robertson
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-19

Review 6.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

7.  BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.

Authors:  Supriya Gaitonde; Surya K De; Marianna Tcherpakov; Antimone Dewing; Hongbin Yuan; Megan Riel-Mehan; Stan Krajewski; Gavin Robertson; Maurizio Pellecchia; Ze'ev Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-17       Impact factor: 4.693

8.  Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4.

Authors:  Giovanna Frazziano; Imad Al Ghouleh; Jeff Baust; Sruti Shiva; Hunter C Champion; Patrick J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

Review 9.  Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma.

Authors:  Fabian V Filipp; Boris Ratnikov; Jessica De Ingeniis; Jeffrey W Smith; Andrei L Osterman; David A Scott
Journal:  Pigment Cell Melanoma Res       Date:  2012-10-01       Impact factor: 4.693

10.  Probing Akt-inhibitor interaction by chemical cross-linking and mass spectrometry.

Authors:  Bill X Huang; Hee-Yong Kim
Journal:  J Am Soc Mass Spectrom       Date:  2009-04-16       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.